Cat. No. | Product name | CAS No. |
DC11536 |
Imigliptin dihydrochloride
A novel potent, selective, orally available DPP-4 inhibitor with IC50 of 9 nM. |
1314944-07-4 |
DC11897 |
Garvagliptin
A potent, selective dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment for type 2 diabetes.. |
1601479-87-1 |
DC11898 |
Gosogliptin
A potent, selective, competitive, orally active dipeptidyl peptidase-4 (DPP-4) inhibitor with IC50 of 13 nM. |
869490-23-3 |
DC11899 |
Gosogliptin dihydrochloride
A potent, selective, competitive, orally active dipeptidyl peptidase-4 (DPP-4) inhibitor with IC50 of 13 nM. |
869490-47-1 |
DC11723 |
AZD-7986(Brensocatib)
Featured
AZD-7986(Brensocatib) is a highly potent, reversible, and selective DPP1 inhibitor with enzyme and cell pIC50 of 8.4. |
1802148-05-5 |
DC8108 |
DBPR108
DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM; no inhibition on DDP8 and DPP9. IC50 value: 15 Nm. |
1186426-66-3 |
DC1105 |
Linagliptin (BI-1356)
Featured
Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM. |
668270-12-0 |
DC7585 |
MK-3102(Omarigliptin)
Featured
MK-3102 (MSD) is a novel DPP-4 Inhibitor, which improves glycaemic control with low risk of symptomatic hypoglycaemia. |
1226781-44-7 |
DC8875 |
Saxagliptin
Featured
Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM and Ki of 1.3 nM. |
361442-04-8 |
DC8739 |
Talabostat mesylate
Talabostat mesilate(PT-100; Val-boroPro) is an orally active, specific inhibitor of dipeptidyl peptidases(IC50=1 nM for DPP4), including tumor-associated fibroblast activation protein. |
150080-09-4 |
DC28139 |
Dutogliptin tartrate
Dutogliptin tartrate (PHX-1149) is an orally available, potent, and selective dipeptidyl peptidase-4 (DPP4) inhibitor for the treatment of type 2 diabetes mellitus. |
890402-81-0 |
DC28358 |
1G244
1G244 is a potent DPP8/9 inhibitor with IC50s of 12 nM and 84 nM, respectively. 1G244 does not inhibit DPPIV and DPPII. 1G244 induces apoptosis in multiple myeloma cells and has anti-myeloma effects. |
847928-32-9 |
DC28382 |
Evogliptin tartrate
Evogliptin tartrate is a potent, orally bioavailable and selective dipeptidyl peptidase-4 (DPP-4) inhibitor, with antidiabetic activity. Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. |
1222102-51-3 |
DC41061 |
NVP-DPP728 dihydrochloride
NVP-DPP728 dihydrochloride is a potent, selective and orally active dipeptidyl peptidase IV (DPP-IV) inhibitor with a Ki of 11 nM. NVP-DPP728 dihydrochloride can be used for the research of diabetes mellitus. |
207556-62-5 |
DC41074 |
Gemigliptin tartrate
Gemigliptin tartrate (LC15-0444 tartrate) is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate exhibits potent anti-glycation properties. Gemigliptin tartrate can be used for the research of advanced glycation end products (AGE)-related diabetic complications. |
1374639-74-3 |
DC41454 |
Azaleatin
Azaleatin is an O-methylated flavonol isolated from Rhododendron species. Azaleatin is a dipeptidyl peptidase-IV inhibitor. Azaleatin can be used for the research of type-2 diabetes and obesity. |
529-51-1 |